Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 4 Warts 1 Uterine Cervical Dysplasia 1 Infections 1 HIV Infections 1 Condylomata Acuminata 1 Cancer Survivor 1 Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 18 Vincristine 15 Zidovudine 11 Bleomycin 11 Cyclophosphamide 9 Etoposide 8 Interferon alpha-2 6 Prednisone 5 Cytarabine 5 tecogalan 4 sargramostim 4 Rituximab 4 Polymerase Chain Reaction 4 Liposomes 4 Filgrastim 4 Dexamethasone 4 Methotrexate 3 Leucovorin 3 Fluorouracil 3 interferon alfa-n1 2 Watchful Waiting 2 Vinblastine 2 Tumor Necrosis Factor-alpha 2 Thalidomide 2 Semaxinib 2 Ritonavir 2 Peripheral Blood Stem Cell Transplantation 2 Mitoxantrone 2 Light Coagulation 2 Isotretinoin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × HIV Infections × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all

NCT03284866 2026-01-28

COVENANT

AIDS Malignancy Consortium

Phase 3 Completed

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡